The bottom line
Nike’s 1 October results come at a critical point for the turnaround.
The company has already made significant strategic changes under Elliott Hill, including refocusing on performance products, rebuilding wholesale relationships and attempting to improve the quality of its inventory. However, the financial results have yet to provide convincing evidence of a sustained recovery.
The immediate outlook remains challenging, with management previously warning that revenue would decline through the first half of fiscal 2027.
The market will therefore be looking beyond the headline earnings figure. A stabilisation in China, stronger performance product, improving wholesale sales and evidence of sustainable margin expansion would all provide important clues about whether Nike’s turnaround is gaining traction.
Conversely, another decline in sales combined with weak China performance and limited evidence of product momentum would reinforce concerns about how long the recovery will take.
With Nike shares already trading close to multi-year lows, expectations have fallen considerably. That makes the guidance and management’s assessment of the path towards a return to growth potentially more important than whether the company narrowly beats or misses quarterly consensus estimates.
The central question on 1 October is therefore straightforward: is Nike still laying the foundations for a recovery, or is the turnaround taking longer than investors had expected?